Sign Up for Free!

Continue Analyzing the page and more.

Already have an Account? Log In

The Trial has ended

Continue Analyzing the page and more.

BioNexus Gene Lab Corp logo

BioNexus Gene Lab Corp

US$2.12

US$4.9m

1.67%

-23.07%

Dashboard Funda..tals Deep..lue Prediction Screener Map

BioNexus Gene Lab Corp Overview

Industry: Specialty Chemicals

Sector: Basic Materials

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

BioNexus Gene Lab Corp is evaluated using Mavefund's quality framework: growing earnings, durable profit margins, conservative leverage, strong return on equity, and disciplined share repurchases.

Score

Price History & Performance

Review BioNexus Gene Lab Corp in context before unlocking the interactive price chart, financial overlays, and downloadable ratio tables.

Recent News



BioNexus Gene Lab Corp Competitors

BioNexus Gene Lab Corp operates in the Specialty Chemicals industry within the Basic Materials sector. Unlock the full page to compare peer rankings, valuation quality, profitability, leverage, and growth trends.

Earnings Per Share

EPS quality is one of the core Mavefund signals. Sign up to continue into the detailed EPS, ROE, margin, share buyback, leverage, and financial ratio analysis.

Continue the analysis

Sign up to unlock ROE, net margin, share buyback, leverage, financial ratios, peer charts, and downloads.

View plans
Ticker Image

BioNexus Gene Lab Corp

US$2.12

US$4.9m

1.67%

-23.07%